All news from Anaesthesiology

Tuberculosis Research: NIAID Releases Strategic Plan

Tuberculosis (TB) is the leading infectious cause of death worldwide, killing roughly 1.6 million people in 2017. In the past 200 years, TB claimed the lives of more than one billion people—more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera, and plague combined.

New Protocol Effective In Identifying Emergency Department Patients

A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.

The study found that use of the HEART Pathway protocol was associated with a 6% reduction in hospitalizations and significant decreases in the median length of hospital stay and use of stress testing and coronary angiography compared to usual care.

These findings demonstrate that the HEART Pathway is a safe and effective way to determine which patients with acute chest pain are low-risk for the acute cardiac syndrome. The study was published in the journal Circulation: Cardiovascular Quality and Outcomes.

Vitamin A Has No Benefits In Treating Atopic Dermatitis

Topical vitamin A provides no benefit in treating atopic dermatitis, whereas topical vitamin D may actually exacerbate symptoms, according to an evidence-based review. Biologic Treatments for Moderate to Severe Atopic Dermatitis.

Topical vitamin A provides no benefit in treating atopic dermatitis, whereas topical vitamin D may actually exacerbate symptoms, according to an evidence-based review. In contrast, topical formulations of vitamins B, C, and E appear to help the disease.

The study was published in the journal Dermatologic Therapy. They also found that three trace elements magnesium, zinc, and iodine seem to improve atopic dermatitis, due to their anti-inflammatory and antimicrobial effects.